Diversified Royalty (TSE:DIV – Get Free Report) received a C$4.00 target price from investment analysts at Ventum Financial in a research report issued on Tuesday, BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Ventum Financial’s price target indicates a potential upside of 36.05% from the stock’s previous close.
Diversified Royalty Stock Performance
DIV traded up C$0.03 during midday trading on Tuesday, reaching C$2.94. The company had a trading volume of 235,855 shares, compared to its average volume of 228,870. Diversified Royalty has a 1 year low of C$2.35 and a 1 year high of C$2.97. The company has a quick ratio of 1.74, a current ratio of 5.73 and a debt-to-equity ratio of 89.69. The company has a market cap of C$486.42 million, a P/E ratio of 14.05 and a beta of 1.56. The business has a 50-day moving average of C$2.81 and a two-hundred day moving average of C$2.80.
Diversified Royalty (TSE:DIV – Get Free Report) last announced its quarterly earnings data on Friday, August 9th. The company reported C$0.05 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of C$0.05. Diversified Royalty had a net margin of 51.17% and a return on equity of 12.02%. The firm had revenue of C$16.78 million during the quarter, compared to analysts’ expectations of C$17.50 million. As a group, equities research analysts predict that Diversified Royalty will post 0.1950568 earnings per share for the current fiscal year.
About Diversified Royalty
Diversified Royalty Corp., a multi-royalty corporation, engages in the acquisition of royalties from multi-location businesses and franchisors in North America. It owns the Sutton, Mr. Lube + Tires, AIR MILES, Mr. Mikes, Nurse Next Door, Oxford Learning Centres, Stratus Building Solutions, and BarBurrito trademarks.
Read More
- Five stocks we like better than Diversified Royalty
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Diversified Royalty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diversified Royalty and related companies with MarketBeat.com's FREE daily email newsletter.